▶ 調査レポート

ポイントオブケア遺伝子検査の世界市場(~2026年)

• 英文タイトル:Global Point-of-Care Genetic Testing Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ポイントオブケア遺伝子検査の世界市場(~2026年) / Global Point-of-Care Genetic Testing Market Size, Status and Forecast 2020-2026 / MRC2-11QY04316資料のイメージです。• レポートコード:MRC2-11QY04316
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はポイントオブケア遺伝子検査のグローバル市場について調査・分析したレポートです。種類別(POCTがんキット、分子POCキット、抗生物質療法におけるPOCT、アッセイカートリッジ、その他)市場規模、用途別(診断ラボ、バイオ製​​薬産業、学術機関、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ポイントオブケア遺伝子検査の競争状況、市場シェア
・世界のポイントオブケア遺伝子検査市場:種類別市場規模 2015年-2020年(POCTがんキット、分子POCキット、抗生物質療法におけるPOCT、アッセイカートリッジ、その他)
・世界のポイントオブケア遺伝子検査市場:種類別市場規模予測 2021年-2026年(POCTがんキット、分子POCキット、抗生物質療法におけるPOCT、アッセイカートリッジ、その他)
・世界のポイントオブケア遺伝子検査市場:用途別市場規模 2015年-2020年(診断ラボ、バイオ製​​薬産業、学術機関、その他)
・世界のポイントオブケア遺伝子検査市場:用途別市場規模予測 2021年-2026年(診断ラボ、バイオ製​​薬産業、学術機関、その他)
・北米のポイントオブケア遺伝子検査市場分析:米国、カナダ
・ヨーロッパのポイントオブケア遺伝子検査市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのポイントオブケア遺伝子検査市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のポイントオブケア遺伝子検査市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのポイントオブケア遺伝子検査市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Abbott (US)、Roche (Switzerland)、Thermo Fisher Scientific (US)、Cepheid (US)、IQuum (US)、Biocartis (Switzerland)、Idaho Technologies (US)、Optigene (UK)、Lumora (UK)
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Point-of-Care Genetic Testing Market
The global Point-of-Care Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Point-of-Care Genetic Testing Scope and Market Size
Point-of-Care Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point-of-Care Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott (US)
Roche (Switzerland)
Thermo Fisher Scientific (US)
Cepheid (US)
IQuum (US)
Biocartis (Switzerland)
Idaho Technologies (US)
Optigene (UK)
Lumora (UK)

Market segment by Type, the product can be split into
POCT Cancer Kits
Molecular POC Kits
POCT In Antibiotic Therapies
Assay Cartridge
Other
Market segment by Application, split into
Diagnostic Labs
Bio-Pharmaceutical Industry
Academic Institutions
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point-of-Care Genetic Testing Revenue
1.4 Market by Type
1.4.1 Global Point-of-Care Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 POCT Cancer Kits
1.4.3 Molecular POC Kits
1.4.4 POCT In Antibiotic Therapies
1.4.5 Assay Cartridge
1.4.6 Other
1.5 Market by Application
1.5.1 Global Point-of-Care Genetic Testing Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic Labs
1.5.3 Bio-Pharmaceutical Industry
1.5.4 Academic Institutions
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Point-of-Care Genetic Testing Market Perspective (2015-2026)
2.2 Global Point-of-Care Genetic Testing Growth Trends by Regions
2.2.1 Point-of-Care Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point-of-Care Genetic Testing Historic Market Share by Regions (2015-2020)
2.2.3 Point-of-Care Genetic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Point-of-Care Genetic Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Point-of-Care Genetic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Genetic Testing Players by Market Size
3.1.1 Global Top Point-of-Care Genetic Testing Players by Revenue (2015-2020)
3.1.2 Global Point-of-Care Genetic Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Point-of-Care Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point-of-Care Genetic Testing Market Concentration Ratio
3.2.1 Global Point-of-Care Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Point-of-Care Genetic Testing Revenue in 2019
3.3 Point-of-Care Genetic Testing Key Players Head office and Area Served
3.4 Key Players Point-of-Care Genetic Testing Product Solution and Service
3.5 Date of Enter into Point-of-Care Genetic Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Point-of-Care Genetic Testing Historic Market Size by Type (2015-2020)
4.2 Global Point-of-Care Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Point-of-Care Genetic Testing Market Size by Application (2015-2020)
5.2 Global Point-of-Care Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Point-of-Care Genetic Testing Market Size (2015-2020)
6.2 Point-of-Care Genetic Testing Key Players in North America (2019-2020)
6.3 North America Point-of-Care Genetic Testing Market Size by Type (2015-2020)
6.4 North America Point-of-Care Genetic Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Point-of-Care Genetic Testing Market Size (2015-2020)
7.2 Point-of-Care Genetic Testing Key Players in Europe (2019-2020)
7.3 Europe Point-of-Care Genetic Testing Market Size by Type (2015-2020)
7.4 Europe Point-of-Care Genetic Testing Market Size by Application (2015-2020)

8 China
8.1 China Point-of-Care Genetic Testing Market Size (2015-2020)
8.2 Point-of-Care Genetic Testing Key Players in China (2019-2020)
8.3 China Point-of-Care Genetic Testing Market Size by Type (2015-2020)
8.4 China Point-of-Care Genetic Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Point-of-Care Genetic Testing Market Size (2015-2020)
9.2 Point-of-Care Genetic Testing Key Players in Japan (2019-2020)
9.3 Japan Point-of-Care Genetic Testing Market Size by Type (2015-2020)
9.4 Japan Point-of-Care Genetic Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Point-of-Care Genetic Testing Market Size (2015-2020)
10.2 Point-of-Care Genetic Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point-of-Care Genetic Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Point-of-Care Genetic Testing Market Size by Application (2015-2020)

11 India
11.1 India Point-of-Care Genetic Testing Market Size (2015-2020)
11.2 Point-of-Care Genetic Testing Key Players in India (2019-2020)
11.3 India Point-of-Care Genetic Testing Market Size by Type (2015-2020)
11.4 India Point-of-Care Genetic Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Point-of-Care Genetic Testing Market Size (2015-2020)
12.2 Point-of-Care Genetic Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Point-of-Care Genetic Testing Market Size by Type (2015-2020)
12.4 Central & South America Point-of-Care Genetic Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott (US)
13.1.1 Abbott (US) Company Details
13.1.2 Abbott (US) Business Overview
13.1.3 Abbott (US) Point-of-Care Genetic Testing Introduction
13.1.4 Abbott (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020))
13.1.5 Abbott (US) Recent Development
13.2 Roche (Switzerland)
13.2.1 Roche (Switzerland) Company Details
13.2.2 Roche (Switzerland) Business Overview
13.2.3 Roche (Switzerland) Point-of-Care Genetic Testing Introduction
13.2.4 Roche (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
13.2.5 Roche (Switzerland) Recent Development
13.3 Thermo Fisher Scientific (US)
13.3.1 Thermo Fisher Scientific (US) Company Details
13.3.2 Thermo Fisher Scientific (US) Business Overview
13.3.3 Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Introduction
13.3.4 Thermo Fisher Scientific (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
13.3.5 Thermo Fisher Scientific (US) Recent Development
13.4 Cepheid (US)
13.4.1 Cepheid (US) Company Details
13.4.2 Cepheid (US) Business Overview
13.4.3 Cepheid (US) Point-of-Care Genetic Testing Introduction
13.4.4 Cepheid (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
13.4.5 Cepheid (US) Recent Development
13.5 IQuum (US)
13.5.1 IQuum (US) Company Details
13.5.2 IQuum (US) Business Overview
13.5.3 IQuum (US) Point-of-Care Genetic Testing Introduction
13.5.4 IQuum (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
13.5.5 IQuum (US) Recent Development
13.6 Biocartis (Switzerland)
13.6.1 Biocartis (Switzerland) Company Details
13.6.2 Biocartis (Switzerland) Business Overview
13.6.3 Biocartis (Switzerland) Point-of-Care Genetic Testing Introduction
13.6.4 Biocartis (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
13.6.5 Biocartis (Switzerland) Recent Development
13.7 Idaho Technologies (US)
13.7.1 Idaho Technologies (US) Company Details
13.7.2 Idaho Technologies (US) Business Overview
13.7.3 Idaho Technologies (US) Point-of-Care Genetic Testing Introduction
13.7.4 Idaho Technologies (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
13.7.5 Idaho Technologies (US) Recent Development
13.8 Optigene (UK)
13.8.1 Optigene (UK) Company Details
13.8.2 Optigene (UK) Business Overview
13.8.3 Optigene (UK) Point-of-Care Genetic Testing Introduction
13.8.4 Optigene (UK) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
13.8.5 Optigene (UK) Recent Development
13.9 Lumora (UK)
13.9.1 Lumora (UK) Company Details
13.9.2 Lumora (UK) Business Overview
13.9.3 Lumora (UK) Point-of-Care Genetic Testing Introduction
13.9.4 Lumora (UK) Revenue in Point-of-Care Genetic Testing Business (2015-2020)
13.9.5 Lumora (UK) Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Point-of-Care Genetic Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Point-of-Care Genetic Testing Revenue
Table 3. Ranking of Global Top Point-of-Care Genetic Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Point-of-Care Genetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of POCT Cancer Kits
Table 6. Key Players of Molecular POC Kits
Table 7. Key Players of POCT In Antibiotic Therapies
Table 8. Key Players of Assay Cartridge
Table 9. Key Players of Other
Table 10. Global Point-of-Care Genetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Point-of-Care Genetic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Point-of-Care Genetic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Point-of-Care Genetic Testing Market Share by Regions (2015-2020)
Table 14. Global Point-of-Care Genetic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Point-of-Care Genetic Testing Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Point-of-Care Genetic Testing Market Growth Strategy
Table 20. Main Points Interviewed from Key Point-of-Care Genetic Testing Players
Table 21. Global Point-of-Care Genetic Testing Revenue by Players (2015-2020) (Million US$)
Table 22. Global Point-of-Care Genetic Testing Market Share by Players (2015-2020)
Table 23. Global Top Point-of-Care Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Genetic Testing as of 2019)
Table 24. Global Point-of-Care Genetic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Point-of-Care Genetic Testing Product Solution and Service
Table 27. Date of Enter into Point-of-Care Genetic Testing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Point-of-Care Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 30. Global Point-of-Care Genetic Testing Market Size Share by Type (2015-2020)
Table 31. Global Point-of-Care Genetic Testing Revenue Market Share by Type (2021-2026)
Table 32. Global Point-of-Care Genetic Testing Market Size Share by Application (2015-2020)
Table 33. Global Point-of-Care Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 34. Global Point-of-Care Genetic Testing Market Size Share by Application (2021-2026)
Table 35. North America Key Players Point-of-Care Genetic Testing Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Point-of-Care Genetic Testing Market Share (2019-2020)
Table 37. North America Point-of-Care Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 38. North America Point-of-Care Genetic Testing Market Share by Type (2015-2020)
Table 39. North America Point-of-Care Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 40. North America Point-of-Care Genetic Testing Market Share by Application (2015-2020)
Table 41. Europe Key Players Point-of-Care Genetic Testing Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Point-of-Care Genetic Testing Market Share (2019-2020)
Table 43. Europe Point-of-Care Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Point-of-Care Genetic Testing Market Share by Type (2015-2020)
Table 45. Europe Point-of-Care Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Point-of-Care Genetic Testing Market Share by Application (2015-2020)
Table 47. China Key Players Point-of-Care Genetic Testing Revenue (2019-2020) (Million US$)
Table 48. China Key Players Point-of-Care Genetic Testing Market Share (2019-2020)
Table 49. China Point-of-Care Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 50. China Point-of-Care Genetic Testing Market Share by Type (2015-2020)
Table 51. China Point-of-Care Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 52. China Point-of-Care Genetic Testing Market Share by Application (2015-2020)
Table 53. Japan Key Players Point-of-Care Genetic Testing Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Point-of-Care Genetic Testing Market Share (2019-2020)
Table 55. Japan Point-of-Care Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Point-of-Care Genetic Testing Market Share by Type (2015-2020)
Table 57. Japan Point-of-Care Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Point-of-Care Genetic Testing Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Point-of-Care Genetic Testing Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Point-of-Care Genetic Testing Market Share (2019-2020)
Table 61. Southeast Asia Point-of-Care Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Point-of-Care Genetic Testing Market Share by Type (2015-2020)
Table 63. Southeast Asia Point-of-Care Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Point-of-Care Genetic Testing Market Share by Application (2015-2020)
Table 65. India Key Players Point-of-Care Genetic Testing Revenue (2019-2020) (Million US$)
Table 66. India Key Players Point-of-Care Genetic Testing Market Share (2019-2020)
Table 67. India Point-of-Care Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 68. India Point-of-Care Genetic Testing Market Share by Type (2015-2020)
Table 69. India Point-of-Care Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 70. India Point-of-Care Genetic Testing Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Point-of-Care Genetic Testing Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Point-of-Care Genetic Testing Market Share (2019-2020)
Table 73. Central & South America Point-of-Care Genetic Testing Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Point-of-Care Genetic Testing Market Share by Type (2015-2020)
Table 75. Central & South America Point-of-Care Genetic Testing Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Point-of-Care Genetic Testing Market Share by Application (2015-2020)
Table 77. Abbott (US) Company Details
Table 78. Abbott (US) Business Overview
Table 79. Abbott (US) Product
Table 80. Abbott (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 81. Abbott (US) Recent Development
Table 82. Roche (Switzerland) Company Details
Table 83. Roche (Switzerland) Business Overview
Table 84. Roche (Switzerland) Product
Table 85. Roche (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 86. Roche (Switzerland) Recent Development
Table 87. Thermo Fisher Scientific (US) Company Details
Table 88. Thermo Fisher Scientific (US) Business Overview
Table 89. Thermo Fisher Scientific (US) Product
Table 90. Thermo Fisher Scientific (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 91. Thermo Fisher Scientific (US) Recent Development
Table 92. Cepheid (US) Company Details
Table 93. Cepheid (US) Business Overview
Table 94. Cepheid (US) Product
Table 95. Cepheid (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 96. Cepheid (US) Recent Development
Table 97. IQuum (US) Company Details
Table 98. IQuum (US) Business Overview
Table 99. IQuum (US) Product
Table 100. IQuum (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 101. IQuum (US) Recent Development
Table 102. Biocartis (Switzerland) Company Details
Table 103. Biocartis (Switzerland) Business Overview
Table 104. Biocartis (Switzerland) Product
Table 105. Biocartis (Switzerland) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 106. Biocartis (Switzerland) Recent Development
Table 107. Idaho Technologies (US) Company Details
Table 108. Idaho Technologies (US) Business Overview
Table 109. Idaho Technologies (US) Product
Table 110. Idaho Technologies (US) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 111. Idaho Technologies (US) Recent Development
Table 112. Optigene (UK) Business Overview
Table 113. Optigene (UK) Product
Table 114. Optigene (UK) Company Details
Table 115. Optigene (UK) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 116. Optigene (UK) Recent Development
Table 117. Lumora (UK) Company Details
Table 118. Lumora (UK) Business Overview
Table 119. Lumora (UK) Product
Table 120. Lumora (UK) Revenue in Point-of-Care Genetic Testing Business (2015-2020) (Million US$)
Table 121. Lumora (UK) Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point-of-Care Genetic Testing Market Share by Type: 2020 VS 2026
Figure 2. POCT Cancer Kits Features
Figure 3. Molecular POC Kits Features
Figure 4. POCT In Antibiotic Therapies Features
Figure 5. Assay Cartridge Features
Figure 6. Other Features
Figure 7. Global Point-of-Care Genetic Testing Market Share by Application: 2020 VS 2026
Figure 8. Diagnostic Labs Case Studies
Figure 9. Bio-Pharmaceutical Industry Case Studies
Figure 10. Academic Institutions Case Studies
Figure 11. Other Case Studies
Figure 12. Point-of-Care Genetic Testing Report Years Considered
Figure 13. Global Point-of-Care Genetic Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Point-of-Care Genetic Testing Market Share by Regions: 2020 VS 2026
Figure 15. Global Point-of-Care Genetic Testing Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Point-of-Care Genetic Testing Market Share by Players in 2019
Figure 18. Global Top Point-of-Care Genetic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point-of-Care Genetic Testing as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Point-of-Care Genetic Testing Revenue in 2019
Figure 20. North America Point-of-Care Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Point-of-Care Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Point-of-Care Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Point-of-Care Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Point-of-Care Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Point-of-Care Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Point-of-Care Genetic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed